Cargando…
Roundabout Guidance Receptor 1 Is an Emerging Prognostic Biomarker for Nasopharyngeal Carcinoma
BACKGROUND: Nasopharyngeal carcinoma (NPC) is a malignant tumor originating from the nasopharynx with high morbidity and mortality in Southeast Asia and south of China. Roundabout guidance receptor 1 (ROBO1) can regulate axonogenesis (axon-like protrusion), which may play an important role in migrat...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310334/ https://www.ncbi.nlm.nih.gov/pubmed/35898392 http://dx.doi.org/10.1177/11795549221113244 |
_version_ | 1784753363468943360 |
---|---|
author | Lee, Sung-Wei Yang, Ching-Chieh Lai, Hong-Yue Tsai, Hsin-Hwa Yeh, Cheng-Fa Kuo, Yu-Hsuan Kang, Nai-Wen Chen, Tzu-Ju Chang, Shih-Lun |
author_facet | Lee, Sung-Wei Yang, Ching-Chieh Lai, Hong-Yue Tsai, Hsin-Hwa Yeh, Cheng-Fa Kuo, Yu-Hsuan Kang, Nai-Wen Chen, Tzu-Ju Chang, Shih-Lun |
author_sort | Lee, Sung-Wei |
collection | PubMed |
description | BACKGROUND: Nasopharyngeal carcinoma (NPC) is a malignant tumor originating from the nasopharynx with high morbidity and mortality in Southeast Asia and south of China. Roundabout guidance receptor 1 (ROBO1) can regulate axonogenesis (axon-like protrusion), which may play an important role in migration. However, the roles of ROBO1 in NPC have not been clarified. METHODS: A comparative analysis employing the NPC transcriptome (GSE12452) and the axonogenesis-related genes (GO: 0050772) was performed. In total, 124 tissue blocks from patients primarily diagnosed as NPC (1993-2002) were examined using immunohistochemical staining. The connections between clinicopathological variables and protein immunoexpression were analyzed by Pearson’s chi-square test. The Kaplan–Meier method with a log-rank test was employed to plot survival curves. Multivariate analysis was performed using the Cox proportional hazards model to identify independent prognostic biomarker. RESULTS: According to transcriptome analysis, we found that ROBO1 is significantly highly expressed in NPC tissues compared with normal tissues. The immunohistochemistry (IHC) staining showed that high expression of ROBO1 was significantly related to primary tumor (T1T2 and T3T4) (P = .024), nodal metastasis status (N0N1 and N2N3) (P = .030), stage (I-II and III-IV) (P = .019), and histological grade (keratinizing, non-keratinizing, and undifferentiated) (P = .065). Importantly, NPC patients with high ROBO1 expression had poorer disease-specific survival (DSS) (P = .0001), distal metastasis-free survival (DMeFS) (P < .0001), and local recurrence-free survival (LRFS) (P = .0001) compared with NPC patients with low ROBO1 expression through the uni-/multivariate and the Kaplan–Meier survival analyses. CONCLUSION: Our report indicates that ROBO1 might be a potential prognostic biomarker for NPC. |
format | Online Article Text |
id | pubmed-9310334 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-93103342022-07-26 Roundabout Guidance Receptor 1 Is an Emerging Prognostic Biomarker for Nasopharyngeal Carcinoma Lee, Sung-Wei Yang, Ching-Chieh Lai, Hong-Yue Tsai, Hsin-Hwa Yeh, Cheng-Fa Kuo, Yu-Hsuan Kang, Nai-Wen Chen, Tzu-Ju Chang, Shih-Lun Clin Med Insights Oncol Special Topic: Head and Neck Cancers: Current Concepts in the Diagnosis, Management, Reconstruction, and Rehabilitation BACKGROUND: Nasopharyngeal carcinoma (NPC) is a malignant tumor originating from the nasopharynx with high morbidity and mortality in Southeast Asia and south of China. Roundabout guidance receptor 1 (ROBO1) can regulate axonogenesis (axon-like protrusion), which may play an important role in migration. However, the roles of ROBO1 in NPC have not been clarified. METHODS: A comparative analysis employing the NPC transcriptome (GSE12452) and the axonogenesis-related genes (GO: 0050772) was performed. In total, 124 tissue blocks from patients primarily diagnosed as NPC (1993-2002) were examined using immunohistochemical staining. The connections between clinicopathological variables and protein immunoexpression were analyzed by Pearson’s chi-square test. The Kaplan–Meier method with a log-rank test was employed to plot survival curves. Multivariate analysis was performed using the Cox proportional hazards model to identify independent prognostic biomarker. RESULTS: According to transcriptome analysis, we found that ROBO1 is significantly highly expressed in NPC tissues compared with normal tissues. The immunohistochemistry (IHC) staining showed that high expression of ROBO1 was significantly related to primary tumor (T1T2 and T3T4) (P = .024), nodal metastasis status (N0N1 and N2N3) (P = .030), stage (I-II and III-IV) (P = .019), and histological grade (keratinizing, non-keratinizing, and undifferentiated) (P = .065). Importantly, NPC patients with high ROBO1 expression had poorer disease-specific survival (DSS) (P = .0001), distal metastasis-free survival (DMeFS) (P < .0001), and local recurrence-free survival (LRFS) (P = .0001) compared with NPC patients with low ROBO1 expression through the uni-/multivariate and the Kaplan–Meier survival analyses. CONCLUSION: Our report indicates that ROBO1 might be a potential prognostic biomarker for NPC. SAGE Publications 2022-07-22 /pmc/articles/PMC9310334/ /pubmed/35898392 http://dx.doi.org/10.1177/11795549221113244 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page(https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Special Topic: Head and Neck Cancers: Current Concepts in the Diagnosis, Management, Reconstruction, and Rehabilitation Lee, Sung-Wei Yang, Ching-Chieh Lai, Hong-Yue Tsai, Hsin-Hwa Yeh, Cheng-Fa Kuo, Yu-Hsuan Kang, Nai-Wen Chen, Tzu-Ju Chang, Shih-Lun Roundabout Guidance Receptor 1 Is an Emerging Prognostic Biomarker for Nasopharyngeal Carcinoma |
title | Roundabout Guidance Receptor 1 Is an Emerging Prognostic Biomarker
for Nasopharyngeal Carcinoma |
title_full | Roundabout Guidance Receptor 1 Is an Emerging Prognostic Biomarker
for Nasopharyngeal Carcinoma |
title_fullStr | Roundabout Guidance Receptor 1 Is an Emerging Prognostic Biomarker
for Nasopharyngeal Carcinoma |
title_full_unstemmed | Roundabout Guidance Receptor 1 Is an Emerging Prognostic Biomarker
for Nasopharyngeal Carcinoma |
title_short | Roundabout Guidance Receptor 1 Is an Emerging Prognostic Biomarker
for Nasopharyngeal Carcinoma |
title_sort | roundabout guidance receptor 1 is an emerging prognostic biomarker
for nasopharyngeal carcinoma |
topic | Special Topic: Head and Neck Cancers: Current Concepts in the Diagnosis, Management, Reconstruction, and Rehabilitation |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9310334/ https://www.ncbi.nlm.nih.gov/pubmed/35898392 http://dx.doi.org/10.1177/11795549221113244 |
work_keys_str_mv | AT leesungwei roundaboutguidancereceptor1isanemergingprognosticbiomarkerfornasopharyngealcarcinoma AT yangchingchieh roundaboutguidancereceptor1isanemergingprognosticbiomarkerfornasopharyngealcarcinoma AT laihongyue roundaboutguidancereceptor1isanemergingprognosticbiomarkerfornasopharyngealcarcinoma AT tsaihsinhwa roundaboutguidancereceptor1isanemergingprognosticbiomarkerfornasopharyngealcarcinoma AT yehchengfa roundaboutguidancereceptor1isanemergingprognosticbiomarkerfornasopharyngealcarcinoma AT kuoyuhsuan roundaboutguidancereceptor1isanemergingprognosticbiomarkerfornasopharyngealcarcinoma AT kangnaiwen roundaboutguidancereceptor1isanemergingprognosticbiomarkerfornasopharyngealcarcinoma AT chentzuju roundaboutguidancereceptor1isanemergingprognosticbiomarkerfornasopharyngealcarcinoma AT changshihlun roundaboutguidancereceptor1isanemergingprognosticbiomarkerfornasopharyngealcarcinoma |